Inhibition of ALOX5 by low-dose Zileuton led to the inhibition of invasion and metastasis in PANC-1 pancreatic cancer cells, and mitigated the M2-like phenotype through the JAK/STAT pathway in macrophages [232]. This evidence concerns the gene SOAT1 and pancreatic neoplasm.